Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Ocular product used to prevent various eye infections. The product is used to treat Endophthalmitis using various ocular procedures.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Diagnostic Equipment
Other Industries
Surgical Devices
Acquirer

Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis‘s full profile, request access.

Request full access to PitchBook